Please login to the form below

Not currently logged in
Email:
Password:

Biomedical Catalyst

This page shows the latest Biomedical Catalyst news and features for those working in and with pharma, biotech and healthcare.

Chancellor’s ‘coronavirus budget’ also pledges big R&D gains

Chancellor’s ‘coronavirus budget’ also pledges big R&D gains

The aim is to “refill” the Biomedical Catalyst, a partnership between the Medical Research Council (MRC) and Innovate UK that provides support for life science projects.

Latest news

More from news
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Interview: Steve Bates, BIA Interview: Steve Bates, BIA

    The investment issue. There have been significant moves towards addressing UK biotech's investment issue through the government's commitment to the Biomedical Catalyst. ... The so-called “funding valley of death” for biotechs may be alleviated by the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • EUSA Pharma founder to chair Glide Pharma EUSA Pharma founder to chair Glide Pharma

    Commenting on the future of Glide Pharma under his direction Morton said: "Having completed a significant investment round earlier this year and winning a large funding award from the UK Biomedical ... Catalyst, the company is well positioned, and I look

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics